Novozymes A/S (OTCMKTS:NVZMY) Stock Rating Upgraded by Zacks Research
by Mitch Edgeman · The Markets DailyNovozymes A/S (OTCMKTS:NVZMY – Get Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.
Several other equities research analysts also recently issued reports on the stock. Rothschild & Co Redburn raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Friday, March 27th. Kepler Capital Markets raised shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Novozymes A/S presently has an average rating of “Buy”.
Get Our Latest Stock Analysis on NVZMY
Novozymes A/S Trading Up 5.0%
OTCMKTS:NVZMY opened at $59.04 on Monday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.67 and a quick ratio of 1.03. The business’s 50-day simple moving average is $59.38 and its 200-day simple moving average is $60.43. Novozymes A/S has a fifty-two week low of $49.90 and a fifty-two week high of $75.99. The stock has a market capitalization of $24.48 billion, a PE ratio of 39.89, a price-to-earnings-growth ratio of 1.05 and a beta of 0.95.
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last posted its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. Novozymes A/S had a return on equity of 6.52% and a net margin of 14.22%. Sell-side analysts expect that Novozymes A/S will post 2.43 earnings per share for the current fiscal year.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).